Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Conditions

Neuromuscular Manifestations 2Neuromuscular Diseases 2Myasthenia Gravis 2

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Diagnostic Self Evaluation × Clear all
NCT06381284 2025-03-25

Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment

ZS Associates

Completed
215 enrolled

Myasthenia Gravis, Neuromuscular Diseases, Neuromuscular Manifestations

NCT06866483 2025-03-10

Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment

ZS Associates

Recruiting
1,000 enrolled

Myasthenia Gravis, Neuromuscular Diseases, Neuromuscular Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡